About The Journal
Recent Advances in Pathology and Laboratory Medicine (RAPL; eISSN: 2454-8642) is a peer-reviewed, open-access Journal purely devoted to the publication of original scientific research findings, methodological developments, and opinions in the form of original and review articles, brief reports, letters to the editor, book-review, proceedings of symposia, debates, perspective and opinions and hypothesis for pathologists and laboratory medicines.
eISSN - 2454-8642
Index Copernicus International, ISA, Google Scholar, DRJI, ESJI, Jour informatics, SIS, BASE, IFSIJ, JSTOR, Infobase index, OAJI.
Open Access Publication and Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows non-commercial use of the work as long as appropriate credit is given. Anyone using any part of our article must notify us and give our URL with the text/figure/table or any other part used. All content is available online, free and without any restrictions. Only the print version of the journal has a charge. Registration is not required to read any article. Anyone using any part of our article should give our URL with the text/figure/table or any other part used. Users can read, download, copy, print, distribute, search, link to the full text of articles for any lawful purpose. Registration is not required to read any article. Authors retain the copyright of their work and can archive pre-print and post-print or published PDF to personal or institutional repositories or libraries without requiring permission from the journal or publisher.
Editor-in-chief has the final say in decisions regarding advertisements or sponsored content, including supplements, the journal will or will not carry, and their decision is final in use of the journal brand and in overall policy regarding commercial use of journal content. Advertisements of brands/products/organizations relevant to the focus and scope of the particular journal only will be considered.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.